ARIXTRA

Manufacturer:

Mylan

Name:

ARIXTRA

HCPCS Code Descriptor:

Injection, fondaparinux sodium, 0.5 mg

Category:

J Code

HCPCS:

J1652

NDC(s):

70710-1515-06, 70710-1514-06, 70710-1514-09, 67457-0595-08, 67457-0594-06, 67457-0593-04, 67457-0592-10, 67457-0584-06, 67457-0585-08, 67457-0582-10, 67457-0583-04, 55150-0233-10, 55150-0232-10, 55150-0230-10, 55150-0231-10, 55111-0681-10, 55111-0681-02, 55111-0680-02, 55111-0680-10, 55111-0679-10, 55111-0679-02, 55111-0678-10, 55111-0678-02, 43598-0606-02, 43598-0606-10, 43598-0609-10, 43598-0609-02, 43598-0608-10, 43598-0608-02, 43598-0607-10, 43598-0607-02, 00781-3476-95, 00781-3465-95, 00781-3476-12, 00781-3454-12, 00781-3454-95, 00781-3465-12, 00781-3443-95, 00781-3443-12

Primary Type:

Anti-coagulant

Generic Status:

Multi-Source

Route of Administration:

Subcutaneous

About:

ARIXTRA is an Anti-coagulant drug manufactured by Mylan and administered via the Subcutaneous route of administration. The J Code: J1652 is aligned to the drug ARIXTRA.